Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

A smart company takes care of its best

Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Metabolic pro heads prefect post

The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.

New nanotech professor to DTU

The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a small illuminating lens.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

LEO Pharma - International Clinical Trial Manager

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.